Muscle synergies in Parkinson's disease before and after the deep brain stimulation of the bilateral subthalamic nucleus.
Marco GhislieriMichele LanotteMarco KnaflitzLaura RizziValentina AgostiniPublished in: Scientific reports (2023)
The aim of this study is to quantitatively assess motor control changes in Parkinson's disease (PD) patients after bilateral deep brain stimulation of the subthalamic nucleus (STN-DBS), based on a novel muscle synergy evaluation approach. A group of 20 PD patients evaluated at baseline (before surgery, T 0 ), at 3 months (T 1 ), and at 12 months (T 2 ) after STN-DBS surgery, as well as a group of 20 age-matched healthy control subjects, underwent an instrumented gait analysis, including surface electromyography recordings from 12 muscles. A smaller number of muscle synergies was found in PD patients (4 muscle synergies, at each time point) compared to control subjects (5 muscle synergies). The neuromuscular robustness of PD patients-that at T 0 was smaller with respect to controls (PD T 0 : 69.3 ± 2.2% vs. Controls: 77.6 ± 1.8%, p = 0.004)-increased at T 1 (75.8 ± 1.8%), becoming not different from that of controls at T 2 (77.5 ± 1.9%). The muscle synergies analysis may offer clinicians new knowledge on the neuromuscular structure underlying PD motor types of behavior and how they can improve after electroceutical STN-DBS therapy.
Keyphrases
- deep brain stimulation
- end stage renal disease
- parkinson disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- skeletal muscle
- peritoneal dialysis
- prognostic factors
- healthcare
- minimally invasive
- palliative care
- patient reported
- patient reported outcomes
- bone marrow
- acute coronary syndrome
- replacement therapy